Adenosine receptor ligands: Differences with acute versus chronic treatment

Trends in Pharmacological Sciences

Volumn 17, Issue 3, 1996, Pages 108-113

  Jacobson, Kenneth A ^a   Von Lubitz, Dag K J E ^b   Daly, John W ^b   Fredholm, Bertil B ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(2 AMINOETHYLAMINO)CARBONYLETHYLPHENYLETHYLAMINO] 5 N ETHYLCARBOXAMIDOADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 8 (3 CHLOROSTYRYL)CAFFEINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR AFFECTING AGENT; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; KFM 19; MDL 102503; NEUROTRANSMITTER RECEPTOR; RECEPTOR SUBTYPE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; BEHAVIOR; BRAIN ISCHEMIA; BRAIN PROTECTION; COGNITION; DOSE TIME EFFECT RELATION; DRUG RESEARCH; HUMAN; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 0030012222     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)10002-X     Document Type: Review

References (50)

1. Nehlig, A., Daval, J-L. and Debry, G. (1992) Brain Res. Rev. 17, 139-169
2. Fredholm, B. B. (1995) Pharmacol. Toxicol. 76, 93-101
3. Daly, J. W. (1993) in Caffeine, Coffee and Health (Garattini, S., ed.), pp. 97-150, Raven Press
4. Johansson, B. et al. (1993) Naunyn-Schmied. Arch. Pharmacol. 347, 407-114
5. Daly, J. W., Shi, D., Nikodijević, O. and Jacobson, K. A. (1994) Pharmacopsychoecologia 7, 201-213
6. Traversa, U., Rosati, A. M., Florio, C. and Vertua, R. (1994) In Vivo 8, 1073-1078
7. Shi, D., Nikodijević, O., Jacobson, K. A. and Daly, J. W. (1993) Cell. Mol. Neurobiol. 13, 247-261
8. Shi, D., Nikodijević, O., Jacobson, K. A. and Daly, J. W. (1995) Arch. Int. Pharmacodyn. Ther. 328, 261-287
9. Marks, M. J., Grady, S. R. and Collins, A. C. (1993) J. Pharmacol. Exp. Ther. 266, 1268-1276
10. Johansson, B., Lindström, K. and Fredholm, B. B. (1994) Neuroscience 59, 837-849
11. Svenningsson, P., Ström, A., Johansson, B. and Fredholm, B. B. (1995) J. Neurosci. 15, 3583-3593
12. Svenningsson, P., Nomikos, G. G. and Fredholm, B. B. (1995) J. Neurosci. 15, 7612-7624
13. Hughes, J. R. et al. (1992) Am. J. Psychiat. 149, 33-40
14. Holtzman, S. G., Mante, S. and Minneman, K. P. (1991) J. Pharmacol. Exp. Ther. 256, 62-68
15. Nikodijević, O., Jacobson, K. A. and Daly, J. W. (1993) Pharmacol. Biochem. Behav. 44, 199-216
16. Nikodijević, O., Jacobson, K. A. and Daly, J. W. (1993) Drug Dev. Res. 30, 104-110
17. Nikodijević, O., Sarges, R., Daly, J. W. and Jacobson, K. A. (1991) J. Pharmacol. Exp. Ther. 259, 286-294
18. Ferré, S., Fuxe, K., Von Euler, G., Johansson, B. and Fredholm, B. B. (1992) Neuroscience 51, 501-512
19. Garrett, B. E. and Holtzman, S. G. (1994) Eur. J. Pharmacol. 262, 65-75
20. Lau, C. E. and Falk, J. L. (1994) Pharmacol Biochem. Behav. 48, 337-344
21. Kaplan, G. B., Greenblat, D. J., Kent, M. A. and Cotreau-Bibbo, M. M. (1993) J. Pharmacol. Exp. Ther. 266, 1563-1572
22. Ahlijanian, M. K. and Takemori, A. E. (1986) Life Sci. 38, 577-588
23. Normile, H. J. and Barraco, R. A. (1991) Brain Res. Bull. 27, 101-104
24. Zarrindast, M. R. and Shafaghi, B. (1994) Eur. J. Pharmacol. 256, 233-239
25. Pontecorvo, M. J., Clissold, D. B., White, M. F. and Ferkany, J. W. (1991) Behav. Neurosci. 105, 521-535
26. Schingnitz, G., Küfner-Mühl, U., Ensinger, H., Lehr, E. and Kuhn, F. J. (1991) Nucleosides Nucleotides 10, 1067-1076
27. Dudley, M. et al. (1994) Drug Dev. Res. 31, 266
28. von Lubitz, D. K. J. E., Paul, I. A., Bartus, R. T. and Jacobson, K. A. (1993) Eur. J. Pharmacol. 249, 271-280
29. Molinengo, L., Scordo, I. and Pastorello, B. (1994) Life Sci. 54, 1247-1250
30. Zhang, G., Franklin, P. H. and Murray, T. F. (1994) Eur. J. Pharmacol. 255, 239-243
31. von Lubitz, D. K. J. E., Paul, I. A. and Jacobson, K. A. (1993) Eur. J. Pharmacol. 249, 265-270
32. Klitgaard, H., Knutsen, L. J. and Thomsen, C. (1993) Eur. J. Pharmacol. 242, 221-228
33. von Lubitz, D. K. J. E. et al. (1995) Eur. J. Pharmacol. 275, 23-29
34. Linden, J. (1994) Trends Pharmacol. Sci. 15, 298-306
35. Georgiev, V., Johansson, B. and Fredholm, B. B. (1993) Brain Res. 612, 271-277
36. Sanders, R. C. and Murray, T. F. (1989) Neurosci. Lett. 101, 325-330
37. von Lubitz, D. K. J. E., Paul, I. A., Ji, X-D., Carter, M. and Jacobson, K. A. (1994) Eur. J. Pharmacol. 253, 95-99
38. Kleinsorge, R. J., Bowers, L. M., Jarvis, M. F. and Berman, R. F. (1993) Drug Dev. Res. 29, 287-291
39. Rudolphi, K. A., Schubert, P., Parkinson, F. E. and Fredholm, B. B. (1992) Trends Pharmacol. Sci. 13, 440-445
40. von Lubitz, D. K. J. E., Carter, M. F., Beenhakker, M., Lin, R. C-S. and Jacobson, K. A. (1995) in Neuroprotective Agents (Trembly, B. and Slikker B., Jr, eds), New York Acad. Sci. 765, 163-178
41. von Lubitz, D. K. J .E., Dambrosia, J. M. and Redmond, D. J. (1989) Neuroscience 30, 451-462
42. von Lubitz, D. K. J. E. et al. (1994) Eur. J. Pharmacol. 256, 161-167
43. von Lubitz, D. K. J. E., Lin, R. C-S. and Jacobson, K. A. (1995) Eur. J. Pharmacol. 287, 295-302
44. Gao, Y. and Phillis, J. W. (1994) Life Sci. 55, 61-65
45. Rudolphi, K. A., Keil, M., Fastbom, J. and Fredholm, B. B. (1989) Neurosci. Lett. 103, 275-280
46. Bona, E., Ådén, U., Fredholm, B. B. and Hagberg, H. (1995) Pediatr. Res. 38, 312-318
47. Webb, R. L., Sills, M. A., Chovan, J. P., Peppard, J. V. and Francis, J. E. (1993) J. Pharmacol. Exp. Ther. 267, 287-295
48. Casati, C. et al. (1994) J. Pharmacol. Exp. Ther. 268, 1506-1511
49. von Lubitz, D. K. J. E., Lin, R. C-S., Popik, P., Carter, M. F. and Jacobson, K. A. (1994) Eur. J. Pharmacol. 263, 59-67
50. Hannon, J. P., Pfannkuche, H. J. and Fozard, J. R. (1995) Br. J. Pharmacol. 115, 945-952